Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

General Medicine

Allergy/Immunology

Autoimmune comorbidity in chronic spontaneous urticaria: A systematic review

Autoimmunity Reviews | Evidence based | Jan 24, 2018 Allergy/Immunology

Immunologic non-inferiority and safety of the investigational pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine (PHiD-CV) 4-dose vial presentation compared to the licensed PHiD-CV 1-dose vial presentation in infants: A phase III randomized study

Vaccine | Jan 24, 2018 Allergy/Immunology

Uncontrolled asthmatics have increased FceRI⁺ and TGF-β positive MC_TC mast cells and collagen VI in the alveolar parenchyma

Clinical & Experimental Allergy | Jan 23, 2018 Allergy/Immunology

Efficacy and safety of dupilumab in perennial allergic rhinitis and comorbid asthma

The Journal of Allergy and Clinical Immunology | Jan 22, 2018 Allergy/Immunology

Randomized clinical trial of a single vs a double dose of 13-valent pneumococcal conjugate vaccine in adults 55 through 74 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine

Vaccine | Jan 22, 2018 Allergy/Immunology

Safety and efficacy of immunotherapy with the recombinant B-cell epitope–based grass pollen vaccine BM32

The Journal of Allergy and Clinical Immunology | Jan 20, 2018 Allergy/Immunology

Perturbations of the gut microbiome genes in infants with atopic dermatitis according to feeding type

The Journal of Allergy and Clinical Immunology | Jan 19, 2018 Allergy/Immunology

The asthma-rhinitis multimorbidity is associated with IgE polysensitization in adolescents and adults

Allergy | Jan 19, 2018 Allergy/Immunology

Efficacy and safety of fezakinumab (an anti-IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments - A randomized, double-blind, phase 2a trial

Journal of the American Academy of Dermatology | Jan 19, 2018 Allergy/Immunology

Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE)

Journal of the American Academy of Dermatology | Jan 19, 2018 Allergy/Immunology

« Prev 1 … 38 39 40 41 42 … 76 Next »

Autoimmune comorbidity in chronic spontaneous urticaria: A systematic review

Immunologic non-inferiority and safety of the investigational pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine (PHiD-CV) 4-dose vial presentation compared to the licensed PHiD-CV 1-dose vial presentation in infants: A phase III randomized study

Uncontrolled asthmatics have increased FceRI⁺ and TGF-β positive MC_TC mast cells and collagen VI in the alveolar parenchyma

Efficacy and safety of dupilumab in perennial allergic rhinitis and comorbid asthma

Randomized clinical trial of a single vs a double dose of 13-valent pneumococcal conjugate vaccine in adults 55 through 74 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine

Safety and efficacy of immunotherapy with the recombinant B-cell epitope–based grass pollen vaccine BM32

Perturbations of the gut microbiome genes in infants with atopic dermatitis according to feeding type

The asthma-rhinitis multimorbidity is associated with IgE polysensitization in adolescents and adults

Efficacy and safety of fezakinumab (an anti-IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments - A randomized, double-blind, phase 2a trial

Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE)

BRI or BMI: What is More Efficient?

Enhancing Conventional Diabetes Management with Lifestyle and Nutritional Interventions

Gut Health Disorders and its Management

Awareness for COPD: MCQ challenge

Addressing Sleep Disorders with Integrative Solutions: From Pharmaceuticals to Natural Remedies

Autoimmune comorbidity in chronic spontaneous urticaria: A systematic review

Immunologic non-inferiority and safety of the investigational pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine (PHiD-CV) 4-dose vial presentation compared to the licensed PHiD-CV 1-dose vial presentation in infants: A phase III randomized study

Uncontrolled asthmatics have increased FceRI+ and TGF-β positive MCTC mast cells and collagen VI in the alveolar parenchyma

Efficacy and safety of dupilumab in perennial allergic rhinitis and comorbid asthma

Randomized clinical trial of a single vs a double dose of 13-valent pneumococcal conjugate vaccine in adults 55 through 74 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine

Safety and efficacy of immunotherapy with the recombinant B-cell epitope–based grass pollen vaccine BM32

Perturbations of the gut microbiome genes in infants with atopic dermatitis according to feeding type

The asthma-rhinitis multimorbidity is associated with IgE polysensitization in adolescents and adults

Efficacy and safety of fezakinumab (an anti-IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments - A randomized, double-blind, phase 2a trial

Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE)

BRI or BMI: What is More Efficient?

Enhancing Conventional Diabetes Management with Lifestyle and Nutritional Interventions

Gut Health Disorders and its Management

Awareness for COPD: MCQ challenge

Addressing Sleep Disorders with Integrative Solutions: From Pharmaceuticals to Natural Remedies

Select Specialty

Select Topic

Uncontrolled asthmatics have increased FceRI⁺ and TGF-β positive MC_TC mast cells and collagen VI in the alveolar parenchyma